Use access key #2 to skip to page content.

dcsilver (< 20)

August 2011



NVAX - UN Reports Bird Flu in Asia

August 31, 2011 – Comments (0) | RELATED TICKERS: NVAX

Haven't seen this anywhere else:  [more]



NVAX, AMRN, EXEL and what’s wrong with CAPS

August 30, 2011 – Comments (1) | RELATED TICKERS: NVAX , EXEL , AMRN




NVAX – Cluster Insider Buys in August

August 23, 2011 – Comments (0) | RELATED TICKERS: NVAX , SIRI , EXEL

You can never tell when a stock has hit its bottom.  For instance, I used to love Sirius (SIRI), I still do, but I kept the faith and rode the stock down from $4.00 a share to $.05.  If I had faith to put in as much money at $.05 as I did at $4.00/$3.00/$2.00/$1.00/$.50, I’d have a lot more money today (who wouldn’t investing with hindsight).  Still I kept buying and watch the invest grow only because I took a big risk when the stock was tanking and being manipulated by shorts and bad long term debt (which I promise, will rear its ugly head again in 2012).  You can read my older blogs to get my thoughts on that though.  [more]



Speculative Biotechs, Government Contracts, and Zzlangerhans – NVAX, PBTH, & SIGA

August 10, 2011 – Comments (2) | RELATED TICKERS: NVAX , SIGAQ , PBTH.DL2

Normally, zzlangerhans is my starting point for identifying speculative biotechs to investigate and trade in.  I find his knowledge useful and more accurate than most filings and websites.  So it’s odd for me to have actually identified three recent stocks that zzlangerhans has green thumbed and noticed they were already in my personal portfolio.  While I normally dabble in biotechs and trade in small banks (SNBC trading at a 52 week low is a personal favorite), out of the blue my personal portfolio has suddenly become heavily balanced in biotechs led by MDP favorite EXEL.  I don’t use CAPS for its intended purposes, I use it more as a tracking mechanism for stocks I like to see when the market inappropriately punishes them and then I pick up a few shares.Let’s look at zzlangerhans thoughts and I’ll add my two cents (which is about all it’s worth)   [more]

Featured Broker Partners